Navigation Links
Written Statement of Kevin J. O'Connor, Chairman of the Department of Justice Task Force on Intellectual Property, at the Senate Judiciary Committee Hearing on Intellectual Property Enforcement
Date:11/7/2007

WASHINGTON, Nov. 7 /PRNewswire-USNewswire/ -- The following is a written statement by Kevin J. O'Connor, Chairman of the Department of Justice Task Force on Intellectual Property, at the Senate Judiciary Committee Hearing on Intellectual Property Enforcement:

-- Introduction

Chairman Leahy, Ranking Member Specter, and Members of the Committee, thank you for the opportunity to discuss the Department of Justice's efforts to protect intellectual property rights through criminal enforcement.

As America continues its transformation into an information- and innovation-based economy, the protection of America's creative assets is a top priority of the Department of Justice. Intellectual property embodies America's cultural heritage, consumer confidence and trust in brands for products ranging from prescription medicines to spark plugs, and most of the assets of our vibrant information industries. As the Committee knows, the majority of the enforcement regime for protecting these intellectual property assets is now and has traditionally been civil. However, with the advent of new technologies, a global supply chain economy, and the increased involvement of transnational criminal organizations, criminal enforcement is now more important than ever in protecting intellectual property rights.

Today, the Department is dedicating more energy and resources than ever before to the protection of U.S. intellectual property rights, with a particular emphasis on health and safety crimes and organized criminal syndicates. The Department has been an integral part of President Bush's Strategy Targeting Organized Piracy, or "STOP", initiative. This initiative involves government officials, local and national law enforcement, small businesses, and international partners in a coordinated and aggressive strategy to fight global intellectual property crime.

Under the umbrella of the STOP initiative and the Department of Justice's Task Force on Intellect
'/>"/>

SOURCE U.S. Department of Justice
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine news :

1. Schwarzenegger Signs Bill to Remove Written Informed Consent for HIV Testing; "Most Important Change in Public HIV/AIDS Policy in Years," Says AHF
2. Statement of Eli Lilly and Company on Dr. David Egilman Settlement:
3. Takeda statement on ACTOS meta-analysis published in the Journal of the American Medical Association
4. Takeda Statement on ACTOS(R) (Pioglitazone HCl) Meta-Analysis Published in the Journal of the American Medical Association
5. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
6. Statement by Oscar S. Wyatt, Jr.
7. Statement from Employment Policies Institute on Senator Hillary Clintons Health Care Plan
8. Pelosi Statement on Proposed Entitlement Task Force
9. Statement by Robert Greenstein, Executive Director of the Center on Budget and Policy Priorities, on the New Congressional SCHIP Agreement
10. Statement on House/Senate Agreement on SCHIP Legislation
11. Statement from the Alliance for Quality Nursing Home Care

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...K,Nov.25/PRNewswire/--Reportlinker.comannouncestha...: ,, TheMarketforAnti-ageingFoods(2ndEdition)...-Market-for-Anti-ageing-Foods-(2nd-Edition ).html ...elopatafastpacewithgrowthoutstrippingthatofconvent...andHealthClaimsDirective,sstrictapproachtohealthcl...
(Date:11/25/2009)...IFFLAKE,N.J.,Nov.25/PRNewswire-FirstCall/--ParPhar...theresultsofits"ModifiedDutchAuction"tenderoffer,i...aggregateprincipalamount,oruptoapproximately82.7%,...eNotesdue2010. ,, BasedonthecountbyAmericanStoc...tenderoffer,$30,805,000aggregateprincipalamountoft...
(Date:11/25/2009)...mily members can panic, underestimate effects of ...lthDay News) -- Thanksgiving is a time of eating t...ng your elderly loved one to the emergency room. ,... why: When family members who have not seen each o...hey are often alarmed by the health of their older...
(Date:11/25/2009)... Beginning Today through Sunday, Novemb...very memory foam and latex sofa bed mattress + an ...ing and a 100 night money back guarantee. Use the ...t to take advantage of this special offer. , ...illions of Americans will travel from Thanksgiving...
(Date:11/25/2009)... The American Society of Hematology (AS...lishing, education, and media company, are launchi...ynamic science curriculum designed to spark intere...ion to exposing students to exciting career opport...Washington (PRWEB) November 25, 2009 -- The Americ...
Breaking Medicine News(10 mins):Health News:Reportlinker Adds The Market for Anti-ageing Foods (2nd Edition) 2Health News:Reportlinker Adds The Market for Anti-ageing Foods (2nd Edition) 3Health News:Reportlinker Adds The Market for Anti-ageing Foods (2nd Edition) 4Health News:Reportlinker Adds The Market for Anti-ageing Foods (2nd Edition) 5Health News:Reportlinker Adds The Market for Anti-ageing Foods (2nd Edition) 6Health News:Par Pharmaceutical Announces Results of Its 'Modified Dutch Auction' Tender Offer 2Health News:ER Visits for Elderly Rise During Thanksgiving 2Health News:ER Visits for Elderly Rise During Thanksgiving 3Health News:Providing Comfort for Holiday Guests Just Got Easier 2Health News:Providing Comfort for Holiday Guests Just Got Easier 3Health News:New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 2Health News:New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 3
...diac Science Corporation (Nasdaq: CSCX ), a glob...ED ) and diagnostic monitoring devices ( ECG , ... rehabilitation ) that connect to EMR and HIS...cheduled a conference call with analysts and inves...
... Income , , POWAY, Calif., April 30 Digirad Corp...head of internal schedules on its 2009 goal of gen... flow. Net income was $44,000 for the first quart...uarter. We previously communicated our 2009 goals...
...thcare training organization has revamped its webs...nced navigation tools, to provide family and profe...resources and training options. , ...family and professional care providers find educat...
...Travel Insurance and Student Funding Group team up...y; Tuition Fee protection programs also added for ...(PRWEB) April 30, 2009 -- With a rise in interest ...unding Group (StuFund) to offer newly created, ine...
...vox UV Air Sterilization Systems are designed to d...swine influenza (H1N1 virus). , ... Sanuvox Technologies has been receiving inquirie...ir Sterilization Systems are designed to destroy a...
...ervention can be modified to teach self-screening ... April 30 A brief intervention program - consisti...ne calls - boosted by tenfold the number of women ...lth Promotion . , , Funded by the National Cance...
Other Medicine News:Health News:Cardiac Science Schedules First Quarter Earnings Release and Announces Conference Call 2Health News:Cardiac Science Schedules First Quarter Earnings Release and Announces Conference Call 3Health News:Digirad Corporation Reports First Quarter 2009 Financial Results 2Health News:Digirad Corporation Reports First Quarter 2009 Financial Results 3Health News:Digirad Corporation Reports First Quarter 2009 Financial Results 4Health News:Digirad Corporation Reports First Quarter 2009 Financial Results 5Health News:Digirad Corporation Reports First Quarter 2009 Financial Results 6Health News:Medifecta Healthcare Training Launches Website with Educational Resources and Online Training for Caregivers 2Health News:New G1G Student Medical Insurance and Student Fee Protection Now on StuFund Web Site 2Health News:New G1G Student Medical Insurance and Student Fee Protection Now on StuFund Web Site 3Health News:Sanuvox UV Air Sterilization Systems Ability to Destroy Airborne Type A Influenza including Swine Flu (H1N1) 2Health News:Sanuvox UV Air Sterilization Systems Ability to Destroy Airborne Type A Influenza including Swine Flu (H1N1) 3Health News:Women Ten Times More Likely To Do Breast Self-Exams Correctly With Intervention Program, Kaiser Permanente Study Finds 2Health News:Women Ten Times More Likely To Do Breast Self-Exams Correctly With Intervention Program, Kaiser Permanente Study Finds 3Health News:Women Ten Times More Likely To Do Breast Self-Exams Correctly With Intervention Program, Kaiser Permanente Study Finds 4
(Date:11/24/2009)...Newswire/--Inadditiontofamily,friendsandhealth,can...toherThanksgivinggratitudelist. ,, "Theyheardth...esaidofMonday,sverdictstotaling$103millionindamage...g12,000womennationwidewhohavesuedWyethandPfizerpha...nandPrempro.Wisneskiandtheothervictimsofhormonethe...
(Date:11/24/2009)...RNewswire/--SpartaSystems,Inc.,themakerofTrackWise...mpliancesolutions,todayannouncedthatSSLInternation...eparentcompanyforgloballyrecognizedbrandssuchasDur...ityManagementSystem(EQMS).Thecompanyisnowleveragin...operationsthatincludeCorrectiveandPreventiveAction...
(Date:11/24/2009)...Newswire-Asia/--HuifengBio-Pharmaceutical,Technolo...dproducer,ofplantextractsandpharmaceuticalrawmater...oductioninXi,an,China,todayreportedthatinits,third..., RevenuesforthequarterendedSept.30,2009were$...23forthesamequarterin2008.Netincome,amountedto1,00...
Breaking Medicine Technology:Maryland Woman Thankful for Wyeth Verdicts 2SSL International plc Embraces TrackWise(R) Software for Global Quality and Compliance Efforts 2SSL International plc Embraces TrackWise(R) Software for Global Quality and Compliance Efforts 3Huifeng Bio-Pharmaceutical Technology Reports 26% Quarterly Revenue Increase 2Huifeng Bio-Pharmaceutical Technology Reports 26% Quarterly Revenue Increase 3Improving schools for disabled students is NJIT researchers mission 59864 1Improving schools for disabled students is NJIT researchers mission 59864 2Improving schools for disabled students is NJIT researchers mission 59864 3Penn team uses self assembly to make molecule sized particles with patches of charge 10447 1Penn team uses self assembly to make molecule sized particles with patches of charge 10447 2Experts Issue Call to Reconsider Screening for Breast Cancer and Prostate Cancer 59862 1Experts Issue Call to Reconsider Screening for Breast Cancer and Prostate Cancer 59862 2Experts Issue Call to Reconsider Screening for Breast Cancer and Prostate Cancer 59862 3Experts Issue Call to Reconsider Screening for Breast Cancer and Prostate Cancer 59862 4Experts Issue Call to Reconsider Screening for Breast Cancer and Prostate Cancer 59862 5Experts Issue Call to Reconsider Screening for Breast Cancer and Prostate Cancer 59862 6
...SCO, Dec. 8 Millennium: The Takeda Oncology Compa...d follow up of patients from the large, internatio...vival improvement for patients with previously unt...nd prednisone (VcMP). The VELCADE combination demo...oups, including those with poor prognostic charact...
...SCO, Dec. 8 Millennium: The Takeda Oncology,Compa...multi-center,randomized Phase III clinical trials ...eatment of transplant-eligible patients with previ...rogression-free survival (PFS) was observed,in one...ith vincristine,adriamycin and dexamethasone (VAD)...
Other Medicine Technology:Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 2Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 3Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 4Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 5Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 6Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 2Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 3Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 4Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 5Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 6Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 7
Kuglen Push-Pull Hook
Serdarevic Suture Hook
Sinskey Hook II
Lewicky Hook
Medicine Products: